{
  "id": 186740,
  "title": "Atossa Therapeutics founder to be selected as NIAID director — report",
  "url": "https://urgent.news/2026/08/05/atossa-therapeutics-founder-to-be-selected-as-niaid-director-report",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-05T18:16:00.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/atossa-therapeutics-founder-to-be-selected-as-niaid-director-report/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Steven Quay, the founder and CEO of clinical-stage biotech Atossa Therapeutics, is likely to be the next director of NIH's National Institute of Allergy and Infectious Diseases, according to a news report. Quay also authored ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}